{"id":5484,"date":"2025-03-14T23:12:12","date_gmt":"2025-03-14T22:12:12","guid":{"rendered":"https:\/\/johann-strauss-apotheke.at\/?p=5484"},"modified":"2025-08-07T10:26:41","modified_gmt":"2025-08-07T08:26:41","slug":"hiv-hazirligi","status":"publish","type":"post","link":"https:\/\/johann-strauss-apotheke.at\/tr\/hiv-prep\/","title":{"rendered":"Trans, non-binary ve inter bireyler i\u00e7in HIV PrEP"},"content":{"rendered":"
\n\t
\n\t\t
\n\t\t\t

PrEP ile kendi kendine korunma<\/h1>\n

Trans, non-binary ve inter bireyler i\u00e7in<\/h3>\n

HIV-negatif trans, non-binary ve inter bireyler HIV maruziyet \u00f6ncesi profilaksi (HIV PrEP) ile kendilerini enfeksiyondan etkili bir \u015fekilde koruma f\u0131rsat\u0131na sahiptir. Bu ila\u00e7, cinsel temas yoluyla bula\u015fmas\u0131 halinde HIV'in v\u00fccutta \u00e7o\u011falmas\u0131n\u0131 \u00f6nler. PrEP'in etkinli\u011fi, hormon al\u0131n\u0131p al\u0131nmad\u0131\u011f\u0131ndan veya cinsiyet de\u011fi\u015ftirme ameliyat\u0131 yap\u0131l\u0131p yap\u0131lmad\u0131\u011f\u0131ndan ba\u011f\u0131ms\u0131zd\u0131r. HIV PrEP'in \u00f6nemli bir avantaj\u0131, HIV negatif ki\u015finin kendi korunmas\u0131n\u0131 kontrol edebilmesi ve ba\u011f\u0131ms\u0131z olarak organize edebilmesidir.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div>

\n\t
\n\t\t\n\t\t
\n\t\t\t
\"HIV<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div><\/div>
\n\t
\n\t\t\n\t\t
\n\t\t\t
\"HIV<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t

HIV nas\u0131l bula\u015f\u0131r?<\/h2>\n

HIV, \u00f6zellikle viral y\u00fck y\u00fcksek oldu\u011funda kan, meni, anal salg\u0131lar ve \u00f6n salg\u0131lar gibi v\u00fccut s\u0131v\u0131lar\u0131 yoluyla bula\u015f\u0131r. Enfeksiyon, bu s\u0131v\u0131lar mukoza zarlar\u0131yla veya anal ya da genital b\u00f6lgedeki k\u00fc\u00e7\u00fck yaralanmalarla temas etti\u011finde ortaya \u00e7\u0131kar. Enfekte kan do\u011frudan bula\u015fabilece\u011finden i\u011fne payla\u015f\u0131m\u0131 da y\u00fcksek risk ta\u015f\u0131r.<\/p>\n

Oral seks, a\u011f\u0131z mukozas\u0131 genellikle vir\u00fcs\u00fc savu\u015fturdu\u011fu i\u00e7in \u00e7ok d\u00fc\u015f\u00fck bir risk ta\u015f\u0131r. Sadece a\u00e7\u0131k yaralarda veya di\u015f eti kanamalar\u0131nda risk artar. Prezervatif veya di\u015f tamponu gibi koruyucu \u00f6nlemler riski daha da azalt\u0131r.<\/p>\n

PrEP ve ART gibi modern tedaviler enfeksiyon riskini \u00f6nemli \u00f6l\u00e7\u00fcde azaltmaktad\u0131r. Ba\u015far\u0131l\u0131 bir antiretroviral tedavi viral y\u00fck\u00fc saptama s\u0131n\u0131r\u0131n\u0131n (\u201eU=U\u201c) alt\u0131na d\u00fc\u015f\u00fcrebilir, bu da HIV'in art\u0131k bula\u015f\u0131c\u0131 olmad\u0131\u011f\u0131 anlam\u0131na gelir. D\u00fczenli testler, enfeksiyonlar\u0131n erken a\u015famada tan\u0131nmas\u0131na ve daha fazla bula\u015fman\u0131n \u00f6nlenmesine yard\u0131mc\u0131 olur.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div>

\n\t
\n\t\t
\n\t\t\t

HIV PrEP almak i\u00e7in do\u011fru yol<\/h2>\n

HIV PrEP'in etkili bir \u015fekilde \u00e7al\u0131\u015fabilmesi i\u00e7in v\u00fccutta yeterli d\u00fczeyde aktif madde birikmesi gerekir. Bunun i\u00e7in net bir al\u0131m stratejisi vard\u0131r:<\/p>\n

Ba\u015flang\u0131\u00e7 a\u015famas\u0131 (HIV PrEP al\u0131m\u0131n\u0131n ba\u015flamas\u0131)<\/h3>\n

Koruyucu etkiyi sa\u011flamak i\u00e7in, ilk cinsel temastan 24 ila 2 saat \u00f6nce 2 tablet al\u0131n\u0131r. Daha sonra her g\u00fcn yakla\u015f\u0131k ayn\u0131 saatte bir tablet daha al\u0131n\u0131r. Bu, koruman\u0131n ba\u015ftan sona s\u00fcrd\u00fcr\u00fclmesini sa\u011flar.<\/p>\n

HIV PrEP kullan\u0131rken, olas\u0131 bir enfeksiyonu erken bir a\u015famada fark edebilmek i\u00e7in d\u00fczenli HIV testleri yap\u0131lmal\u0131d\u0131r. Bu, bir enfeksiyon tespit edilirse derhal tedavi edilmesine olanak tan\u0131r. \u0130laca kar\u015f\u0131 diren\u00e7 geli\u015fmesini \u00f6nlemek i\u00e7in d\u00fczenli t\u0131bbi kontrollerin yap\u0131lmas\u0131 da \u00f6nemlidir.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div>

\n\t
\n\t\t\n\t\t
\n\t\t\t
\"HIV'e<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div><\/div>
\n\t
\n\t\t\n\t\t
\n\t\t\t
\"HIV'e<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t

\u00c7\u0131k\u0131\u015f a\u015famas\u0131 (HIV PrEP'in sonland\u0131r\u0131lmas\u0131)<\/h3>\n

HIV PrEP kesildi\u011finde, ila\u00e7 seviyesinin \u00e7ok k\u0131sa s\u00fcrede d\u00fc\u015fmemesini sa\u011flamak i\u00e7in dikkatli olunmal\u0131d\u0131r. Gerekli s\u00fcre fiziksel konfig\u00fcrasyona ba\u011fl\u0131d\u0131r:<\/p>\n

Dx2 \u015femas\u0131 (son seksten 2 g\u00fcn sonra al\u0131n\u0131r)<\/strong><\/p>\n